<GlossaryTerm id="CDR0000045468"><TermName>motexafin gadolinium</TermName><TermPronunciation>(moh-TEK-suh-fin GA-doh-LIH-nee-um)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment and diagnosis of some types of cancer. It builds up in some cancer cells, which may make them easier to kill with radiation therapy and chemotherapy. Motexafin gadolinium is also used in magnetic resonance imaging (MRI) to help find cancer cells in the body. It is a type of radiosensitizing agent, a type of chemosensitizing agent, and a type of contrast agent. Also called gadolinium texaphyrin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705503" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;motexafin gadolinium&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705502" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gadolinio motexafina&quot;" language="es" id="_4"/><SpanishTermName>gadolinio motexafina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Puede aumentar la sensibilidad de las células tumorales a la radioterapia, mejorar las imágenes del tumor con el uso de la imaginología por resonancia magnética (IRM) y destruir las células cancerosas. Es un tipo de complejo de metaloporfirina. También se llama gadolinio texapirina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2013-04-01</DateLastModified></GlossaryTerm>
